213 related articles for article (PubMed ID: 25964979)
1. Obstacles to the universal application of INNs.
Prescrire Int; 2014 Oct; 23(153):248-51. PubMed ID: 25964979
[TBL] [Abstract][Full Text] [Related]
2. How INNs are created. Making drug names safer by contributing to INN selection.
Prescrire Int; 2015 Jun; 24(161):162-5. PubMed ID: 26436175
[TBL] [Abstract][Full Text] [Related]
3. Think INN, prescribe INN, dispense INN: good professional practice.
Prescrire Int; 2000 Dec; 9(50):184-90. PubMed ID: 11475502
[TBL] [Abstract][Full Text] [Related]
4. International Nonproprietary Names (INN) for pharmaceutical substances.
Kopp-Kubel S
Bull World Health Organ; 1995; 73(3):275-9. PubMed ID: 7614659
[TBL] [Abstract][Full Text] [Related]
5. Naming drug substances at the national level: mainly in the United Kingdom and the United States.
Prescrire Int; 2012 Nov; 21(132):279. PubMed ID: 23210269
[TBL] [Abstract][Full Text] [Related]
6. Common stems: international nonproprietary names (INNs): common INN stems provide key information.
Prescrire Int; 2007 Oct; 16(91):192. PubMed ID: 17926829
[No Abstract] [Full Text] [Related]
7. Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names.
Bryan R; Aronson JK; ten Hacken P; Williams A; Jordan S
PLoS One; 2015; 10(12):e0145431. PubMed ID: 26701761
[TBL] [Abstract][Full Text] [Related]
8. "Biosimilars": towards fewer obstacles to their use.
Prescrire Int; 2015 Mar; 24(158):80-1, 83. PubMed ID: 25897464
[TBL] [Abstract][Full Text] [Related]
9. Exceptions to and deviations from the INN common stem system.
Prescrire Int; 2013 May; 22(138):138-9. PubMed ID: 23819186
[TBL] [Abstract][Full Text] [Related]
10. Drug name recognition and classification in biomedical texts. A case study outlining approaches underpinning automated systems.
Segura-Bedmar I; Martínez P; Segura-Bedmar M
Drug Discov Today; 2008 Sep; 13(17-18):816-23. PubMed ID: 18602492
[TBL] [Abstract][Full Text] [Related]
11. [Development of the database on nonproprietary names of drugs].
Hashiba S; Takenaka Y; Nakadate M
Eisei Shikenjo Hokoku; 1989; (107):141-5. PubMed ID: 2636918
[TBL] [Abstract][Full Text] [Related]
12. [Common international names and trademarks in the pharmaceutical field].
Pasotti V
Boll Chim Farm; 1989 Apr; 128(4):121-4. PubMed ID: 2775524
[TBL] [Abstract][Full Text] [Related]
13. What's in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications.
Serafini M; Cargnin S; Massarotti A; Tron GC; Pirali T; Genazzani AA
J Med Chem; 2021 Apr; 64(8):4410-4429. PubMed ID: 33847110
[TBL] [Abstract][Full Text] [Related]
14. The INNs and outs of antibody nonproprietary names.
Jones TD; Carter PJ; Plückthun A; Vásquez M; Holgate RG; Hötzel I; Popplewell AG; Parren PW; Enzelberger M; Rademaker HJ; Clark MR; Lowe DC; Dahiyat BI; Smith V; Lambert JM; Wu H; Reilly M; Haurum JS; Dübel S; Huston JS; Schirrmann T; Janssen RA; Steegmaier M; Gross JA; Bradbury AR; Burton DR; Dimitrov DS; Chester KA; Glennie MJ; Davies J; Walker A; Martin S; McCafferty J; Baker MP
MAbs; 2016; 8(1):1-9. PubMed ID: 26716992
[TBL] [Abstract][Full Text] [Related]
15. International Conference on Harmonisation; S10 Photosafety Evaluation of Pharmaceuticals; guidance for industry; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2015 Jan; 80(17):4282-3. PubMed ID: 25730921
[TBL] [Abstract][Full Text] [Related]
16. Generic drug names and social welfare.
Lobo F; Feldman R
J Health Polit Policy Law; 2013 Jun; 38(3):573-97. PubMed ID: 23418366
[TBL] [Abstract][Full Text] [Related]
17. International nonproprietary names for monoclonal antibodies: an evolving nomenclature system.
Guimaraes Koch SS; Thorpe R; Kawasaki N; Lefranc MP; Malan S; Martin ACR; Mignot G; Plückthun A; Rizzi M; Shubat S; Weisser K; Balocco R
MAbs; 2022; 14(1):2075078. PubMed ID: 35584276
[TBL] [Abstract][Full Text] [Related]
18. Current regulatory and scientific considerations for approving biosimilars in Iran.
Hadavand N; Valadkhani M; Zarbakhsh A
Biologicals; 2011 Sep; 39(5):325-7. PubMed ID: 21873077
[TBL] [Abstract][Full Text] [Related]
19. [Biosimilars--opportunity or threat?].
Swierkot J
Wiad Lek; 2013; 66(2 Pt 2):200-5. PubMed ID: 25775818
[TBL] [Abstract][Full Text] [Related]
20. International Nonproprietary Names (INN). A World Health Organization activity.
Jerome JB; Luback PM
J Am Med Womens Assoc (1972); 1972 Oct; 27(10):536-8. PubMed ID: 4342347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
